OGI
OGI
NASDAQ · Pharmaceuticals

Organigram Global Inc

$0.99
+0.00 (+0.00%)
As of Aug 8, 10:30 PM ET ·
Financial Highlights (FY 2026)
Revenue
401.11M
Net Income
-38,312,932
Gross Margin
6.6%
Profit Margin
-9.6%
Rev Growth
+21.1%
D/E Ratio
0.22
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 6.6% 6.6% 34.9% 34.9%
Operating Margin -8.4% -7.6% 19.9% 18.1%
Profit Margin -9.6% -9.1% 18.8% 16.0%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 401.11M 331.11M 81.33M 78.64M
Gross Profit 26.63M 21.99M 28.34M 27.41M
Operating Income -33,853,694 -25,151,332 16.21M 14.22M
Net Income -38,312,932 -28,464,288 15.27M 12.59M
Gross Margin 6.6% 6.6% 34.9% 34.9%
Operating Margin -8.4% -7.6% 19.9% 18.1%
Profit Margin -9.6% -9.1% 18.8% 16.0%
Rev Growth +21.1% +21.1% -3.5% +20.8%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 16.84M 16.84M 25.95M 29.36M
Total Equity 75.96M 75.96M 132.90M 143.87M
D/E Ratio 0.22 0.22 0.20 0.20
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -21,952,381 -17,215,421 21.57M 20.37M
Free Cash Flow 16.42M 10.74M